Pharmaceutical and biotechnology companies with a drug product in
clinical development are usually focused on a quick commercial launch.
Secondary packaging aspects are often less considered. Correlations with
secondary packaging (in this context, secondary packaging also includes
device assembly and serialization) that are not considered in this
phase can have a negative effect on:
· further processability
· options in the product lifecycle management
· cost and time-to-market More info >>
pAVEway™ expression system for the efficient expression of therapeutic proteins
Fujifilm Diosynth Biotechnologies
One of the major bottlenecks in the production of biopharmaceuticals is
the efficient expression of therapeutic proteins in microbial or
mammalian cells. The Escherichia coli pAVEway™ expression system
described here has been developed to ensure high product titres and
efficient scale up to GMP manufacture, whilst minimising many common
issues seen in other expression systems, such as ‘leaky’ expression
(expression of recombinant protein in the absence of inducer). More info >>
Arena International are delighted to announce the return of Outsourcing
in Clinical Trials Europe. Part of our global series of events, this
flagship show will attract the leading clinical professionals from
across Europe. The 10th Annual event will be hosted in Paris. More info >>
